Yunnan Botanee Bio-Technology GroupLTD Past Earnings Performance
Past criteria checks 1/6
Yunnan Botanee Bio-Technology GroupLTD has been growing earnings at an average annual rate of 9.4%, while the Personal Products industry saw earnings growing at 7.9% annually. Revenues have been growing at an average rate of 20.9% per year. Yunnan Botanee Bio-Technology GroupLTD's return on equity is 9.9%, and it has net margins of 9.7%.
Key information
9.4%
Earnings growth rate
6.5%
EPS growth rate
| Personal Products Industry Growth | 7.8% |
| Revenue growth rate | 20.9% |
| Return on equity | 9.9% |
| Net Margin | 9.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders
Nov 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 02Recent updates
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders
Nov 02Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?
Oct 19The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More
Sep 27Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?
Sep 25Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year
Jun 03A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)
May 24Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 02Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet
Feb 29Revenue & Expenses Breakdown
How Yunnan Botanee Bio-Technology GroupLTD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6,108 | 592 | 3,535 | 317 |
| 30 Jun 24 | 5,959 | 791 | 3,235 | 304 |
| 31 Mar 24 | 5,756 | 775 | 3,145 | 298 |
| 31 Dec 23 | 5,522 | 757 | 3,036 | 299 |
| 30 Sep 23 | 5,550 | 1,113 | 2,712 | 310 |
| 30 Jun 23 | 5,332 | 1,106 | 2,590 | 282 |
| 31 Mar 23 | 5,069 | 1,064 | 2,424 | 258 |
| 01 Jan 23 | 5,014 | 1,051 | 2,390 | 255 |
| 30 Sep 22 | 4,805 | 1,025 | 2,353 | 171 |
| 30 Jun 22 | 4,660 | 993 | 2,270 | 152 |
| 31 Mar 22 | 4,323 | 930 | 2,107 | 121 |
| 01 Jan 22 | 4,022 | 863 | 1,932 | 113 |
| 30 Sep 21 | 3,332 | 683 | 1,622 | 85 |
| 30 Jun 21 | 3,107 | 648 | 1,450 | 82 |
| 31 Mar 21 | 2,825 | 568 | 1,378 | 72 |
| 31 Dec 20 | 2,636 | 544 | 1,281 | 63 |
| 31 Dec 19 | 1,944 | 412 | 984 | 51 |
| 31 Dec 18 | 1,240 | 261 | 632 | 43 |
| 31 Dec 17 | 798 | 154 | 415 | 28 |
Quality Earnings: 300957 has a large one-off gain of CN¥186.1M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300957's current net profit margins (9.7%) are lower than last year (20.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300957's earnings have grown by 9.4% per year over the past 5 years.
Accelerating Growth: 300957's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300957 had negative earnings growth (-46.8%) over the past year, making it difficult to compare to the Personal Products industry average (-6%).
Return on Equity
High ROE: 300957's Return on Equity (9.9%) is considered low.